Certolizumab pegol for treating rheumatoid arthritis after inadequate response to a TNF-alpha inhibitor

  • Technology appraisal guidance
  • TA415
  • Published: 
Download guidance (PDF)

Update information

Minor changes since publication

June 2021: Recommendation 1.4 added on equality when using the disease activity score.

ISBN: 978-1-4731-2127-0